Objective: To assess the incidence of healthcare-associated infections (HAI) and the prevalence
|
|
- Damon Rodgers
- 6 years ago
- Views:
Transcription
1
2 Abstract Objective: To assess the incidence of healthcare-associated infections (HAI) and the prevalence of pathogens across all pediatric units within a single hospital, and trends in pediatric HAI over a 5-year time period for both device and non-device-associated HAI. Setting: Four units within an academic acute tertiary care hospital in the United States: pediatric intensive care unit, newborn critical care center, children s intermediate and cardiac care, and pediatric nursing units. Patients: Hospitalized children (<18 years of age). Methods: Review of prospectively obtained, comprehensive hospital-wide surveillance, , from an 806-bed acute care academic hospital. Surveillance data was obtained by trained infection control professionals using CDC/NHSN criteria for HAI. Results: Over the five-year study period, the leading types of HAI were CLASBI (18.55%), tracheobronchitis (18.03%), and UTI (12.16%). The highest overall infection rate per 1,000 patient-days was in the PICU (11.23), followed by the CICC (4.96), the NCCC (3.87), and the inpatient floors (2.83). The overall infection rate decreased in all pediatric units with the greatest decline in the PICU. The incidence of CLASBI, CAUTI, and UTI decreased significantly, while the incidence of VAP, NVAP, and BSI did not change significantly. From the 954 identified HAI cases, 1131 pathogens were isolated including Staphylococcus aureus (n=156, 13.79%), Escherichia coli (n=104, 9.20%), and Enterococcus sp (n=103, 9.11%). Conclusion: Pediatric HAI decreased in incidence. Future research is needed to determine the interventions that have driven this decline and to better understand the lower relative percentages of antimicrobial-resistant pathogens in pediatric versus adult populations.! "!
3 Introduction Healthcare-associated infections (HAI) (i.e., infections acquired in a healthcare setting), are a major concern for patient safety and health outcomes among hospitalized patients. These infections, which include bloodstream infections (BSI), urinary tract infections (UTI), pneumonia and respiratory infections, surgical site infections (SSI), and others, are associated with morbidity, mortality, increased length of stay, and increased financial costs for patients. 1 The Centers for Disease Control and Prevention (CDC) reported an estimated 721,800 HAI among 648,000 patients in U.S. acute care hospitals in 2011 although comprehensive child-specific data are not publically available. 2 HAI have received increased attention in recent years and are now viewed within the medical community as a largely preventable public health concern; a recent study found that up to 70% of such infections are reasonably preventable using current evidencebased strategies. 3 However, the majority of research, discussion, and preventative practices have focused on adult patients. Differences in susceptibility to infection and response to preventative measures between adults and children are evident in the differing rates of central line-associated BSI (CLABSI), SSI, ventilator-associated pneumonia (VAP), and catheter-associated UTI (CAUTI) in national data. 4,5 Although several important studies have examined pediatric HAI within a hospital setting, these studies typically focused on a single hospital unit, a single type of infection, or an analysis of prevalence at a single point in time. 6-9 Furthermore, the majority of literature focuses solely on device-associated HAI. Therefore, a comprehensive longitudinal review of HAI (including those that are non-device-associated) within all pediatric units is warranted. The overall goal of this study is to add to the evidence base around pediatric HAI in hopes of better understanding risk factors and effective preventative measures and ultimately reducing future infection within the pediatric hospitalized population. Our specific study aims were to determine: (1) differences in HAI incidence across all pediatric units within a single hospital, (2) prevalence of pathogenic sources of HAI within a single hospital, and (3) trends in pediatric HAI incidence over a 5-year time period for both device and non-device-associated HAI.! "!
4 Methods This study was conducted at University of North Carolina (UNC) Hospitals, an 806-bed tertiary care facility. During the period analyzed, 2008 through 2012, infection control surveillance was conducted by 5 infection control professionals supervised by 3 full time faculty (DJW, WAR, EES- B). Comprehensive hospital-wide surveillance included all CDC-defined sites and was performed in accordance with CDC/NHSN (National Health Care Safety Network) criteria. This research was approved by the institutional review board of UNC Chapel Hill. The study population was comprised of all patients under 18 years of age hospitalized between 2008 and There were four pediatric units included in this study: the 20-bed pediatric intensive care unit (PICU), 58-bed newborn critical care center (NCCC), 8-bed children s intermediate and cardiac care (CICC), and 64-bed pediatric nursing unit(s). BSI included both primary infections (i.e., those not related to a secondary site) and secondary infections (i.e., bacteremia associated with infection at another site). In accordance with CDC criteria, primary bloodstream infections were considered central catheter associated if the patient had a catheter in place for more than 48 hours prior to infection and a secondary site of infection was not identified. Respiratory infections included pneumonia, empyema, and other infections of the respiratory tract; tracheobronchitis was reported separately. Pneumonia was categorized as ventilator-associated if the patient had been intubated and received ventilation for more than 48 hours prior to the development of pneumonia; otherwise, it was considered hospital acquired (i.e. non-ventilator associated) pneumonia (NVAP). Sources for identification of HAI included laboratory reports of positive culture results, results of serological testing or molecular tests (e.g., polymerase chain reaction), morbidity and mortality conferences, autopsies, and reports of infections from clinics and physicians (such as SSI). Infections with an onset 48 or more hours after admission were considered to be healthcareassociated. For patients who moved from one hospital location to another, infections that! "!
5 developed within 48 hours after admission to a new unit were categorized as occurring in the previous unit. Cases were entered into a computerized database after having been reviewed by a nurse supervisor and a physician who specialized in infectious diseases and critical care medicine. Data available from this prospectively maintained database include the patient s name, age, sex, admission date, date of infection onset, hospital location, site of infection, presence of indwelling device(s), and infecting pathogen(s). The antimicrobial susceptibilities of the infecting pathogens were recorded on patient case forms but were not entered into the computerized database, with the exception of methicillin-resistant S. aureus (MRSA), vancomycin resistant Enterococcus (VRE) species, and multi-drug resistant Pseudomonas aeruginosa (MDRPA). Only pathogens associated with nosocomial infections that met CDC criteria were included in our database (i.e., patients who were colonized but not infected were not included in this study). The infection rate was defined as the number of nosocomial infections per 1,000 patient days. Device associated infection rates were calculated as the number of device associated infections for a specified body site per 1,000 device-days. The device utilization ratio was calculated as the number of device-days per number of patient-days. Preliminary analyses were conducted in Excel, and SAS software was used for subsequent analyses of trend-lines and statistical significance. The study did not assess specific infections by unit and year due to the instability of the data due to small numerators. Results This study utilized data from the children s units at UNC Hospitals. During the five-year period of the study, there were 6,179 total reported HAI at UNC Hospitals. Of these, 15.44% (954) were in pediatric patients.! "!
6 Infection Rates across Units Over the full five-year study period, the leading types of HAI were CLASBI (18.55%), tracheobronchitis (18.03%), and UTI (12.16%). VAP (8.81%) and CAUTI (7.02%) also comprised a sizeable percentage of total infections. One-sixth of infections (16.67%) were an assortment of other less-common infections including gastroenteritis, conjunctivitis, and meningitis. (Table 1) Over the study period, the highest overall infection rate per 1,000 patient-days was in the PICU (11.23), followed by the CICC (4.96), the NCCC (3.87), and the nursing units (2.83). The highest rates of both CLASBI (3.35 per 1,000 central line-days) and BSI (0.33 per 1,000 patient-days) were in the CICC. The highest rates of both CAUTI (4.01 per 1,000 catheter days) and UTI (0.94 per 1,000 patient days) were in the PICU. The highest rate of VAP (4.19 per 1,000 ventilator days) was in the NCCC while the highest non-device pneumonia rate (0.45 per 1,000 patient days) was in the PICU. The rate of tracheobronchitis was higher in the PICU (3.66 per 1,000 patient days) than the other units included in this study. The PICU and the nursing units saw the highest rates of SSI (0.64 and 0.45 per 1,000 patient days, respectively). (Table 2). Pathogenic Source of Infection From the 954 HAI cases identified over the study period, 1131 pathogens were isolated and reported, averaging 1.19 pathogens per infection. The most predominant pathogenic sources of infection were Staphylococcus aureus (n=156, 13.79%), Escherichia coli (n=104, 9.20%), Enterococcus sp (n=103, 9.11%), coagulase negative staphyloccocus (n=101, 8.93%), and Pseudomonas aeruginosa (n=96, 8.49%). Figure 1 shows the top ten pathogens responsible for HAI at the study site over the five-year period. Antimicrobial-resistant pathogens accounted for 7.69% of all identified pathogens in this study. Overall, 48.72% (n=76) of Staphylococcus aureus infections were oxacillin-resistant pathogens. Nearly one-tenth (9.71%, n=10) of Enterococcus species were resistant to vancomycin. Of 96 identified Pseudomonas aeruginosa pathogens, 1.05% (n=1) was multi-drug resistant.! "!
7 For respiratory infections, the most predominant pathogens were Staphylococcus aureus (17.69%, n=72), Pseudomonas aeruginosa (12.53%, n=51), and Enterobacter cloacae (8.11%, n=33). A notable difference between device and non-device infections was seen in Escherichia coli, which was responsible for nearly four times as many infections in non-device respiratory infections (5.96%) compared to device infections (1.64%). For bloodstream infections, the most predominant pathogens were coagulase negative staphylococcus (21.24%, n=55), Enterococcus species (14.67%, n=38), and Staphylococcus aureus (11.20%, n=29). Coagulase negative staphylococcus was the leading cause of bloodstream infection for both CLASBI and BSI. For urinary tract infections, the most predominant pathogens were Escherichia coli (23.30%, n=48), Enterococcus species (20.39%, n=42), and Candida species (10.68%, n=22). The pathogenic trends for device and non-device urinary tract infections were largely similar, although Candida was responsible for three times as many CAUTI compared to non-device UTI. For SSI, Staphylococcus aureus (19.79%, n=19), Escherichia coli (16.67%, n=16), and coagulase negative staphylococcus (12.50%, n=12) were the leading causing of infection. (Table 3) Longitudinal Trends and Devices The overall patient infection rate decreased over the five-year study period in all pediatric units. The greatest decrease was seen in the PICU, where incidence declined 42.00% from 2008 to 2012 (p<0.01). This was followed by the NCCC, nursing units and CICC. As seen in Figure 2, over the five-year study period, the incidence of CLASBI and CAUTI decreased significantly. The incidence rate difference was per 1,000 central-line days (p=0.02) and per 1,000-catheter days (p=0.02). The incidence of UTI also decreased by infections per 1,000 patient days (p=0.05). The incidence of VAP (-3.11 per 1000 ventilator days, p=0.11), NVAP (-0.11 infections per 1,000 patient days, p=0.12), and BSI (+0.10 infections per 1,000 patient days, p=0.24) did not change significantly over the same period. Over the fiveyear period, the percentage of total bloodstream infections that were non-device related grew! "!
8 from 10.45% in 2008 to 40.00% in 2012 and the percentage of total pneumonia infections that were non-device rated grew from 26.32% to 38.89%. Discussion This study is the largest and most comprehensive assessment of pediatric HAI in the published literature. The study aimed to determine (1) differences in HAI incidence across all pediatric units within a single hospital, (2) prevalence of pathogenic sources of HAI within a single hospital, and (3) trends in pediatric HAI incidence over a 5-year time period for both device and non-deviceassociated HAI. In analyzing five years of data from an academic hospital, we found that pediatric HAI trends have largely aligned with trends seen in the adult population, with several notable exceptions (detailed below). As expected, given the different patient populations and disease burdens, we found that HAI incidence varied substantially among the four pediatric hospital units. Considering all infections together, the highest incidence per 1,000 patient days was seen in the PICU, followed by the CICC, the NCCC, and the inpatients floors. This study supports previous research that found high HAI rates within pediatric intensive care units. 9,10 The PICU rate was nearly four-times higher than the rate among the nursing units, and this is likely due to greater severity of disease and immune deficiencies, and more frequent and lengthy device usage in the PICU. Per the data in Table 3, compared to all other pediatric units, the PICU had the highest device utilization ratio (ratio of device days to total patient days) for Foley-days, central line-days, and ventilator-days. Although device-associated infections are decreasing, devices still carry a substantial risk for HAI; high PICU infection rates are therefore unsurprising and attention to reducing these rates is needed. The study further demonstrated that the top ten pathogenic sources of infection make up more than three-fourths of all identified pathogens. Of the top four pathogens, three were Gram-positive cocci (Staphylococcus aureus, Enterococcus sp, Staphylococcus coagulase negative) and one was Gram-negative (E. coli). Of the remaining six pathogens, three were nonenteric pathogens! "!
9 (Pseudomonas aeruginosa, Candida sp, Clostridium difficile) and three were enteric pathogens (Enterobacter cloacae, Klebsiella pneumoniae, Serratia marcescens). The study found that HAI declined among the study population in all four units over the five-year period. That CLASBI and CAUTI declined significantly is a promising finding, since critically ill pediatric patients frequently require device intervention, and it suggests that such devices may not increase the risk of infection as greatly as in the past. However, the lack of significant decline in VAP (which comprised nearly 9% of infections within the study population) indicates that a focus on infection prevention in the PICU and NCCC (the two units in which ventilators are utilized) is needed. Although UTI rates declined significantly over the five-year period, incidence rates of non-device pneumonia and BSI have remained stagnant. Compared to overall patient data from the CDC s National Healthcare Safety Network (NHSN), which tracks device-associated HAI nationally, pathogenic sources of HAI among this pediatric population are quite similar. 11 Although the rank order differs slightly, the top eight pathogens among both patient populations are identical. However, patterns of antimicrobial-resistance differed. 11 Compared with NHSN, the pediatric population at UNC had lower relative percentages of overall drug-resistant pathogenic isolates (20% vs. 7.69%, respectively), oxacillin resistance among Staphylococcus aureus (56.2% vs. 48.7%, respectively), vancomycin resistance among Enterococcus species (33.3% vs. 9.7%, respectively), and multi-drug resistance among Pseudomonas aeruginosa (>6.0% vs. 1.1%, respectively). 11 Small numbers did not allow for statistical analysis of multi-drug resistance by individual unit, but previous research has found minimal differences in resistance trends among hospital units. 11 The five-year pediatric infection trends differ from previously published trends found among the general patient population over the same time period within the same hospital. 12 In both populations, HAI rates saw rapid declines from , driven by declines in deviceassociated HAI. 12 However, the general population saw significant declines in all device-! "!
10 associated HAI, including VAP, while this infection did not decline significantly among pediatric patients. Further research is needed to understand why the decline in VAP among adult patients has not carried over to children. Additionally, the general population saw no significant changes in infection rates for any non-device HAI, while the pediatric population saw a significant decline in UTI. An exploration of interventions enacted among pediatric units during this timeframe may help determine UTI-reduction strategies that can be applied to an adult patient population. For both populations, device-associated infection incidence remains notably higher than incidence of nondevice infections, but this gap is narrowing as device-associated infections decline more rapidly. 12 The study was strengthened by its large patient population, inclusion of data from all pediatric units within a single hospital over five years, and use of surveillance data from trained infection prevention specialists. The inclusion of nursing unit data here is notable because most literature does not include a focus on these units, despite the presence of infection. Furthermore, the inclusion of five years of data from a single location allows for a temporal analysis that cannot be conducted from the CDC s NHSN data alone. The inclusion of pathogenic data and breakout by device and non-device HAI adds to the existing literature base around pediatric HAI. Study results are limited in that they come from a single academic site and longitudinal data is over only five years, resulting in some small sample sizes. Larger samples sizes would have allowed us to assess specific infections by unit and year, and compare infection-specific longitudinal trends among units. As healthcare-associated infections persist and a focus on hospital epidemiology continues to build, the need for pediatric-specific data and prevention plans will be of greater importance. The CDC s NHSN is the nation s most widely used healthcare-associated infection tracking system with data from more than 12,000 medical facilities, but pediatric reporting is very limited. 13,14 Greater surveillance and reporting for pediatric patients, including specific breakout of drugresistant pathogenic isolates in children, would increase the sample size for analyses and allow for better understanding of the disease burden of pediatric HAI. There is also a need for! "!
11 increased focus on non-device HAI among both pediatric and general patient populations. Although device-associated HAI continue to comprise the majority of infections, this balance is shifting as device-associated infections decline more rapidly and non-device infections remain relatively stable. 10 Declines in device-associated HAI in adult patients have been largely driven by the introduction of device-focused guidelines, bundles, and new technologies, as well as a focus in traditional surveillance on device-associated infections, but it is unclear whether these are sufficient for infection reduction in children as well. 10,12, 15 Research on prevention of both device and non-device infections should be undertaken in pediatric and adult populations. Finally, there is a need for pediatric-specific HAI definitions and quality control programs. Current definitions from the CDC and NHSN are nearly identical for children and adults, despite known differences in susceptibility and prevention. 9,16 Existing quality control efforts such as the Surgical Care Improvement Project, a national effort from the Joint Commission to reduce post-surgical complications, apply only to patients 18 and older. Comparable programs are needed for pediatric patients. Increased funding and research are key when considering pediatric HAI, because the disease burden is high while the knowledge base remains thin. Pediatric patients are a unique population, and several of the findings in this study highlight differences between this population and a general patient population in regard to longitudinal infection trends and patterns of pathogenic resistance. Further reductions in pediatric HAI are undeniably important and with targeted research, increased knowledge and pediatric-specific guidelines unquestionably possible. Acknowledgments I am grateful for the generous support of Dr. David J. Weber, Dr. Tamar Ringel-Kulka, Dr. William Rutala, Dr. Emily Sickbert-Bennett, and Lauren M. DiBiase, from the Division of Infectious Diseases, the Department of Hospital Epidemiology, and the Department of Maternal and Child Health at the University of North Carolina, Chapel Hill, NC. Their feedback, analyses, and expertise were invaluable throughout the process of writing this paper.! "#!
12 References 1. Haley RW, Schaberg DR, Crossley KB, Von Allmen SD, McGowan JE. Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. Am J Med. 1981;70: Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care associated infections. N Engl J Med. 2014;370(13): Umscheid CA, Rajender Agarwal MD M, Kendal Williams MD M, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011;32(2): Foster CB, Sabella C. Health care associated infections in children. JAMA. 2011;305(14): Harris JS. Pediatric Nosocomial Infections: Children Are Not Little Adults. Infect Control Hosp Epidemiol Nov;18(11): Wisplinghoff H, Seifert H, Tallent SM, Bischoff T, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J. 2003;22(8): Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. Pediatrics. 1999;103(4):e39-e Sohn AH, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr Dec;139(6): Gravel D, Matlow A, Ofner-Agostini M, Loeb M, et al. A point prevalence survey of health care associated infections in pediatric populations in major Canadian acute care hospitals. Am J Infect Control Apr;35(3): National Nosocomial Infections Surveillance System. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October Am J Infect Control. 2004;32(8): ! ""!
13 11. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, Infect Control Hosp Epidemiol. 2013;34(1): DiBiase LM, Weber DJ, Sickbert-Bennett EE, Anderson DJ, Rutala WA. The growing importance of non-device-associated healthcare-associated infections: a relative proportion and incidence study at an academic medical center, Infect Control Hosp Epidemiol Feb;35(2): doi: / Epub 2014 Jan Centers for Disease Control and Prevention. About NHSN. November Available at gov/nhsn/about.html. Accessed March 28, Dudeck MA, Weiner LM, Allen-Bridson K, et al. National Healthcare Safety Network (NHSN) report, data summary for 2012, device-associated module. Am J Infect Control. 2013;41 (12): Miller MR, Griswold M, Harris JM II, et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics. 2010;125(2): Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health careassociated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5): ! "#!
14 Tables Table 1: Frequency of HAI by Type and Year, % (N), among pediatric inpatients at UNC Hospitals, Total CLABSI (60) (38) (35) (26) (18) (177) BSI 2.97 (7) 2.48 (5) 4.91 (8) 3.06 (6) 7.64 (12) 3.98 (38) VAP (28) 9.41 (19) 5.52 (9) 8.67 (17) 7.01 (11) 8.81 (84) NVAP 4.24 (10) 5.45 (11) 4.29 (7) 2.55 (5) 4.46 (7) 4.19 (40) TRACHEOBRONCHITIS (31) (37) (37) (41) (26) (172) OTHER RESPIRATORY TRACT INFECTION 0.00 (0) 0.99 (2) 1.84 (3) 5.10 (10) 1.27 (2) 1.78 (17) SSI - SUPERFICIAL 2.97 (7) 5.45 (11) 3.68 (6) 2.55 (5) 3.82 (6) 3.67 (35) SSI - DEEP 0.42 (1) 0.99 (2) 1.84 (3) 3.06 (6) 1.91 (3) 1.57 (15) SSI - ORGAN/SPACE 0.85 (2) 5.45 (11) 3.07 (5) 5.10 (10) 3.82 (6) 3.56 (34) CAUTI 8.90 (21) 6.44 (13) 7.98 (13) 5.61 (11) 5.73 (9) 7.02 (67) UTI (36) (26) (17) (23) 8.92 (14) (116) OTHER (33) (27) (20) (36) (43) (159) Total 100% (236) 100% (202) 100% (163) 100% (196) 100% (157) 100% (954) Key: CLABSI, central line-associated bloodstream infections; BSI, bloodstream infections; VAP, ventilator-associated pneumonia; NVAP, non-ventilator-associated pneumonia, SSI, surgical site infections, CAUTI, catheter-associated urinary tract infection; UTI, urinary tract infections.! "#!
15 Table 2: Frequency (N) and infection rate of HAI by type and unit in pediatric inpatients at UNC Hospitals, PICU CICC NCCC NU Total CLABSI (N) BSI (N) VAP (N) NVAP (N) TRACHEOBRONCHITIS (N) OTHER RESPIRATORY TRACT INFECTION (N) SSI SUPERFICIAL (N) SSI DEEP (N) SSI - ORGAN/SPACE (N) CAUTI (N) UTI (N) OTHER (N) Total (N) Total Patient Days OVERALL PATIENT DAY INFECTION RATE (PER 1,000 PATIENT DAYS) BSI (PER 1,000 PATIENT DAYS) NVAP (PER 1,000 PATIENT DAYS) UTI PER (1,000 PATIENT DAYS) Total Central Line Days CLABSI RATE (PER 1000 CENTRAL LINE DAYS) Total Foley Days * CAUTI RATE (PER 1000 FOLEY CATHETER DAYS) 4.01 * Total Ventilator Days * * VAP RATE (PER 1000 VENTILATOR DAYS) 2.29 * 4.19 * 3.18 *Device is not utilized within this unit KEY: PICU, pediatric intensive care unit; CICC, children s intermediate and cardiac care; NCCC, newborn critical care center, NU, nursing units; CLABSI, central line-associated bloodstream infections; BSI, bloodstream infections; VAP, ventilator-associated pneumonia; NVAP, nonventilator-associated pneumonia, SSI, surgical site infections, CAUTI, catheter-associated urinary tract infection; UTI, urinary tract infections! "#!
16 Table 3: Pathogenic isolates by infection type and device association, % (n), in pediatric inpatients at UNC Hospitals, Total Rank Staphylococcus aureus* 1 Escherichia coli 2 Enterococcus sp* 3 Staphylococcus coagulase negative 4 Pseudomonas aeruginosa* 5 Enterobacter cloacae 6 Klebsiella pneumoniae 7 Overall BSI UTI Respiratory SSI Other Total % Nondevice Non- (n) Device Total Device device Total Device Non-device Total Total Total (156) 9.35 (20) (9) (29) 1.33 (1) 3.82 (5) 2.91 (6) (21) (51) (72) (19) (30) (104) 4.67 (10) (5) 5.79 (15) (19) (29) (48) 1.64 (2) 5.96 (17) 4.67 (19) (16) 3.68 (6) 9.11 (103) (35) 6.67 (3) (38) (10) (32) (42) 1.64 (2) 2.46 (7) 2.21 (9) 7.29 (7) 3.68 (6) 8.93 (101) (43) (12) (55) 4.00 (3) 2.29 (3) 2.91 (6) 3.28 (4) 2.46 (7) 2.70 (11) (12) (17) 8.49 (96) 6.54 (14) 0.00 (0) 5.41 (14) 6.67 (5) 6.87 (9) 6.80 (14) (15) (36) (51) 7.29 (7) 6.13 (10) 6.19 (70) 7.94 (17) 4.44 (2) 7.34 (19) 2.67 (2) 5.34 (7) 4.37 (9) (17) 5.61 (16) 8.11 (33) 5.21 (5) 2.45 (4) 5.92 (67) 7.01 (15) 4.44 (2) 6.56 (17) 8.00 (6) 8.4 (11) 8.25 (17) 5.74 (7) 6.67 (19) 6.39 (26) 6.25 (6) 0.61 (1) 5.39 Candida sp 8 (61) 9.35 (20) 2.22 (1) 8.11 (21) (14) 6.11 (8) (22) 1.64 (2) 1.75 (5) 1.72 (7) 3.13 (3) 4.91 (8) Clostridium difficile 9 (57) 0.00 (0) 0.00 (0) 0.00 (0) 0.00 (0) 0.00 (0) 0.00 (0) 0.00 (0) 0.00 (0) 0.00 (0) 0.00 (0) (57) Serratia 4.07 marcescens 10 (46) 4.21 (9) 2.22 (1) 3.86 (10) (2) 0.76 (1) 1.46 (3) 7.38 (9) 6.67 (19) 6.88 (28) 3.13 (3) 1.23 (2) Other** (270) (31) (10) (41) (13) (26) (39) (43) (108) (151) (18) (22) 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total (1131) (214) (45) (259) (75) (131) (206) (122) (285) (407) (96) (163) *Includes antimicrobial-resistant pathogens **Rhinovirus/Enterovirus, gram negative rods, Stenotrophomonas maltophilia, Klebsiella oxytoca, RSV, Proteus mirabilis, Enterobacter aerogenes, Beta streptocococcus group b, Citrobacter sp, Haemophilus influenzae, influenza, Acinetobacter, Torulopsis glabrata, Streptococcus viridans group, Streptococcus sp, Bacillus cereus, Parainfluenza, diphtheroids, Moraxella catarrhalis, Klebsiella sp, rotavirus, Streptococcus agalactiae, parvovirus, Asperigillus fumagatus, Lactobacillus sp, Stomatococcus mucilaginosus, yeast, Acrhomobacter sp, Bacteriodes fragilis, Chlamydia trachomatis, Clostridium butyricum, Neisseria sp (saprophytic strain), Staphylococcus epidermis, Streptococcus mitis!! "#!
17 Figures Figure 1: Number of identified pathogenic isolates STAPHYLOCOCCUS AUREUS Ten pathogenic sources of infection in pediatric inpatients at UNC Hospitals, ESCHERICHIA COLI ENTEROCOCCUS SP STAPHYLOCOCCUS COAGULASE NEGATIVE PSEUDOMONAS AERUGINOSA 70 ENTEROBACTER CLOACAE KLEBSIELLA PNEUMONIAE CANDIDA SP CLOSTRIDIUM DIFFICILE 46 SERRATIA MARCESCENS Figure 2: Incidence of device-associated and non-device-associated infections in pediatric inpatients with 5-year trend lines at University of North Carolina (UNC) Hospitals, Infection Rate per 1000 Days at Risk Non-device-associated pneumonia and ventilator-associated pneumonia rates per 1,000 days at risk, pediatric inpatients, UNC Hospitals, p= NVAP PER 1,000 PATIENT DAYS p=0.12 VAP RATE PER 1,000 VENTILATOR DAYS! "#!
18 Infection Rate per 1,000 Days at Risk Non-device-associated bloodstream infection and central line associated bloodstream infection rates per 1,000 days at risk, pediatric inpatients, UNC Hospitals, p=0.02 p= BSI PER 1,000 PATIENT DAYS CLABSI RATE PER 1,000 CENTRAL LINE DAYS Non-device-associated urinary tract infection and catheterassociated urinary tract infection rates per 1,000 days at risk, pediatric inpatients, UNC Hospitals, Infection Rate per 1,000 Days at Risk p=0.02 p= UTI PER 1,000 PATIENT DAYS CAUTI RATE PER 1,000 FOLEY CATHETER DAYS! "#!
Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host
Goals Microbiology of Healthcare-associated Infections William A. Rutala, Ph.D., M.P.H. Director, Statewide Program for Infection Control and Epidemiology and Research Professor of Medicine, University
More informationHEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY
HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health
More informationURINARY TRACT INFECTIONS: Focus on CA UTIs
URINARY TRACT INFECTIONS: Focus on CA UTIs William A. Rutala, Ph.D., M.P.H. Director, Statewide Program for Infection Control and Epidemiology and Research Professor of Medicine, University of North Carolina
More informationSurveillance of Surgical Site Infection in Surgical Hospital Wards in Bulgaria,
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 01 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.701.361
More informationHealthcare-associated infections acquired in intensive care units
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Healthcare-associated infections acquired in intensive care units Key facts In 2015, 11 788 (8.3%) of patients staying in an intensive care unit
More informationNosocomial infections surveillance in RIPAS Hospital
Original Article Brunei Int Med J. 212; 8 (6): 32-333 Nosocomial infections surveillance in RIPAS Hospital Muppidi SATYAVANI, 1, 2 Junita MOMIN, ² and Samuel Kai San YAPP 2, 3 ¹ Department of Microbiology,
More informationSurveillance of Healthcare Associated Infections in Scottish Intensive Care Units
Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units Annual report of data from January 2010 to December 2010 Scottish Intensive Care Society Audit Group 1 Health Protection
More informationSurveillance of Healthcare Associated Infections in Scottish Intensive Care Units
Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units Annual report of data from January - December 2012 Scottish Intensive Care Society Audit Group Health Protection Scotland
More informationPneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention. Basics of Infection Prevention 2-Day Mini-Course 2016
Pneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention Basics of Infection Prevention 2-Day Mini-Course 2016 Objectives Differentiate long term care categories of respiratory infections
More informationSep Oct Nov Dec Total
LB PAGE 2 LB PAGE 3 Sep Oct Nov Dec 2007 2007 2007 2007 Total Repeat Information Total Repeats 35 15 17 9 76 Repeat Rate 6.01% 0.17% 1.12% 0.39% 2.07% Repeat Chemistry 25 0 2 0 27 Repeat Extraction 1 0
More informationSURVEILLANCE BLOODSTREAM INFECTIONS IN BELGIAN HOPITALS ( SEP ) RESULTS ANNUAL REPORT data
SURVEILLANCE BLOODSTREAM INFECTIONS IN BELGIAN HOPITALS ( SEP ) RESULTS ANNUAL REPORT data 2000-2014 SEP Workgroup Meeting 24 June 2015 Dr. Naïma Hammami Dr. Marie-Laurence Lambert naima.hammami@wiv-isp.be
More informationPreventing & Controlling the Spread of Infection
Preventing & Controlling the Spread of Infection Contributors: Alice Pong M.D., Hospital Epidemiologist Chris Abe, R.N., Senior Director Ancillary and Support Services Objectives Review the magnitude of
More informationINFECTIOUS DISEASE. Page 2
Infectious disease Advantages OF TESTING INFECTIOUS DISEASE We are in the middle of a paradigm shift in infectious disease diagnostic testing. As we move from targeted infectious disease testing to a syndromic
More informationEpidemiology of Infectious Complications of H1N1 Influenza Virus Infection
Epidemiology of Infectious Complications of H1N1 Influenza Virus Infection Lyn Finelli, DrPH, MS Lead, Influenza Surveillance and Outbreak Response Epidemiology and Prevention Branch Influenza Division
More informationEpidemiological Surveillance of Bacterial Nosocomial Infections in the Surgical Intensive Care Unit
DOI: 10.5455/msm.2014.26.7-11 Received: 18 November 2013; Accepted: 55 February 2014 AVICENA 2014 ORIGINAL PAPER Mater Sociomed. 2014 Feb; 26(1): 7-11 Epidemiological Surveillance of Bacterial Nosocomial
More informationNHSN Catheter-Associated Urinary Tract Infection Surveillance in 2016
NHSN Catheter-Associated Urinary Tract Infection Surveillance in 2016 Presented by: Susan Steeves MSN, RN, CNL, CIC June 28,2016 Taken from: NHSN Training 2016 March 3, 2016 Eileen Scalise, MSN, RN Nurse
More informationM O L E C U L A R G E N E T I C S
MOLECULAR GENETICS ADVANTAGES OF MOLECULAR GENETICS Molecular genetics is a dynamic and transformative area of diagnostics, leading to insights in research and treatment in many disease states that are
More informationCefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010
Cefotaxime Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European
More informationSurveillance of Healthcare Associated Infections in Scottish Intensive Care Units
Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units Annual report of data from January 2011 to December 2011 Scottish Intensive Care Society Audit Group Health Protection
More informationRunning head: REDUCING HOSPITAL- ACQUIRED INFECTIONS 1
Running head: REDUCING HOSPITAL- ACQUIRED INFECTIONS 1 Reducing Hospital-Acquired Infections Corinne Showalter University of South Florida REDUCING HOSPITAL- ACQUIRED INFECTIONS 2 Abstract Clinical Problem:
More informationCatheter-Associated Urinary Tract Infection (CAUTI) Event
Catheter-Associated Urinary Tract Infection () Event Introduction: Urinary tract infections (UTIs) are tied with pneumonia as the second most common type of healthcare-associated infection, second only
More informationDISEASE OUTBREAKS SUMMARY
DISEASE OUTBREAKS SUMMARY Outbreaks may be defined as (a) clusters of cases related in time and place or (b) occurrence of disease above a baseline or threshold level in a defined location. In Los Angeles
More informationNancy Hailpern, Director, Regulatory Affairs K Street, NW, Suite 1000 Washington, DC 20005
Summary of Infection Prevention Issues in the Centers for Medicare & Medicaid Services (CMS) FY 2014 Inpatient Prospective Payment System (IPPS) Final Rule Hospital Readmissions Reduction Program-Fiscal
More informationEPIDEMIOLOGY AND TRENDS OF IMPORTANT PEDIATRIC HEALTHCARE-ASSOCIATED INFECTIONS AT SIRIRAJ HOSPITAL, THAILAND
Pediatric Healthcare Associated Infections at Siriraj Hospital EPIDEMIOLOGY AND TRENDS OF IMPORTANT PEDIATRIC HEALTHCARE-ASSOCIATED INFECTIONS AT SIRIRAJ HOSPITAL, THAILAND Nootwadee W Asanathong 1,4,
More information2016:26: % [1] Frederick Foley 9,600 25% [2,3] DOI: /ICJ
203 1,3 1,2,3 1 2 3 2016:26:203-209 Frederick Foley 4 95% [1] 9,600 25% [2,3] 105 6 15 105 8 31 201 02-28757462 DOI: 10.6526/ICJ.2016.503 105 10 204 [4-6] ( ) (extraluminal infection) (endogenous) 70%
More information2018 CNISP HAI Surveillance Case definitions
2018 CNISP HAI Surveillance Case definitions The following case definitions for the surveillance of healthcare-associated infections (HAIs) are used by all acute-care hospitals that participate in the
More informationEnhanced EARS-Net Surveillance 2017 First Half
1 Enhanced EARS-Net Surveillance 2017 First Half In this report Main results for 2017, first half Breakdown of factors by organism and resistance subtype Device-association Data quality assessment Key
More informationInfluenza A (H1N1)pdm09 in Minnesota Epidemiology
Influenza A (H1N1)pdm09 in Minnesota Epidemiology Infectious Disease Epidemiology, Prevention and Control Division PO Box 64975 St. Paul, MN 55164-0975 Number of Influenza Hospitalizations by Influenza
More informationConsultation on the Revision of Carbapenem Breakpoints
Consultation on the Revision of Carbapenem Breakpoints July 2018 Please send comments to the EUCAST Scientific Secretary at jturnidge@gmail.com by September 15. EUCAST revision of carbapenem breakpoints
More informationCOMMUNICABLE DISEASE REPORT Quarterly Report
COMMUNICABLE DISEASE REPORT Quarterly Report Volume 31, Number 3 December 2014 Healthcare-Associated Infections In past issues of the Communicable Disease Report the focus has been on antibiotic-resistant
More informationEnhanced EARS-Net Surveillance REPORT FOR 2012 DATA
Enhanced EARS-Net Surveillance REPORT FOR DATA 1 In this report Main results for Proposed changes to the enhanced programme Abbreviations Used Here BSI Bloodstream Infections CVC Central Venous Catheter
More informationTreatment of febrile neutropenia in patients with neoplasia
Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece
More informationThe Clinical Significance of Blood Cultures. Presented BY; Cindy Winfrey, MSN, RN, CIC, DON- LTC TM, VA- BC TM
The Clinical Significance of Blood Cultures Presented BY; Cindy Winfrey, MSN, RN, CIC, DON- LTC TM, VA- BC TM OVERVIEW Blood cultures are considered an important laboratory tool used to diagnose serious
More informationAntisepsis Bath and Oral.. Should We Change Practice? DR AZMIN HUDA ABDUL RAHIM
Antisepsis Bath and Oral.. Should We Change Practice? DR AZMIN HUDA ABDUL RAHIM Chlorhexidine Exposure in ICU Chlorhexidine gluconate Long acting topical antiseptic In use since 1954 Water soluble Remains
More informationUniversity of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology
University of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology This material is supported in part by unrestricted educational
More informationSUPPLEMENTARY MATERIAL
SUPPLEMENTARY MATERIAL (A) Further inclusion criteria and categorisation of ICD-10 diagnostic codes Pneumonia: A310 Pulmonary mycobacterial infection A420 Pulmonary actinomycosis A481 Legionnaires' disease
More informationComputer-Assisted Surveillance for Detecting Clonal Outbreaks of Nosocomial Infection
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2004, p. 1170 1175 Vol. 42, No. 3 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.3.1170 1175.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationObjectives. Healthcare-Associated Infections in Neonates and Young Children. HAIs in Children and Adults. Magnitude of the Problem
Objectives Healthcare-Associated Infections in Neonates and Young Children Aaron Milstone, M.D. M.H.S. Associate Professor, Pediatrics and Epidemiology Associate Hospital Epidemiologist Johns Hopkins Medical
More informationReviews in Infection
Reviews in Infection RIF 1(1):1-6 (2010) RIF ISSN:1837-6746 Original Research Infection related processes during haemodialysis: A study in General Hospital Haemodialysis unit Naser Hussain 1, *Mona F.
More informationInfectious Diseases-HAI Idaho Department of Health and Welfare, Division of Public Health Boise, Idaho. Assignment Description
Infectious Diseases-HAI Idaho Department of Health and Welfare, Division of Public Health Boise, Idaho Assignment Description The Fellow s assignments will primarily focus on projects within the HAI and
More informationIP Lab Webinar 8/23/2012
2 What Infection Preventionists need to know about the Laboratory Anne Maher, MS, M(ASCP), CIC Richard VanEnk PhD, CIC 1 Objectives Describe what the laboratory can do for you; common laboratory tests
More informationCefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010
Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the
More informationSurgical site infections
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Surgical site infections Key facts Surgical site infections (SSIs) are among the most common healthcare-associated infections (HAIs). They are
More informationActivity C: ELC Prevention Collaboratives
Surgical Site Infection (SSI) Toolkit Activity C: ELC Prevention Collaboratives S.I. Berríos-Torres, MD Division of Healthcare Quality Promotion Centers for Disease Control and Prevention Draft - 12/21/09
More informationSustained Antimicrobial Activity of a Novel Disinfectant Against Healthcare Pathogens
Sustained Antimicrobial Activity of a Novel Disinfectant Against Healthcare Pathogens William A. Rutala, PhD, MPH, Maria F. Gergen MT (ASCP), Emily E. Sickbert-Bennett, PhD, Deverick J. Anderson, MD, MPH,
More informationGUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 47: Carbapenem-resistant Enterobacteriaceae Authors E-B Kruse, MD H. Wisplinghoff, MD Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key Issue Known
More informationNHSN and Public Reporting. Linda R. Greene, RN,MPS,CIC Manager Infection Prevention Highland Hospital Rochester, NY linda_
1 NHSN and Public Reporting Linda R. Greene, RN,MPS,CIC Manager Infection Prevention Highland Hospital Rochester, NY linda_ greene@urmc.rochester.edu 2 Objectives Describe challenges and opportunities
More informationCatheter-Associated Urinary Tract Infection (CAUTI) Event
Catheter-Associated Urinary Tract Infection () Event Introduction: The urinary tract is the most common site of healthcare-associated infection, accounting for more than 30% of infections reported by acute
More informationNational Surveillance of Infections acquired in Intensive Care Units
National Surveillance of Infections acquired in Intensive Care Units Annual Report 2015 Public Health & Surveillance Healthcare-associated infections and Antimicrobial resistance Juliette Wytsmanstraat
More informationThe Year in Infection Control
The Year in Infection Control Andie Lee Departments of Infectious Diseases and Microbiology Royal Prince Alfred Hospital Sydney, Australia 1 1.223 million Pubmed publications last 12 months 2 Selection
More informationOutbreak investigation of nosocomial infections
Definitions Outbreak investigation of nosocomial infections School of Public Health, HSUM March 2012 Walter Popp, University Clinics Essen, Germany Epidemia increased number of cases, limited in time and
More informationONE STEP (Lemon, Mint, Pine) Detergent for Cleaning, Disinfecting and Deodorizing
SUMMARY OF ANTIMICROBIAL ACTIVITY ONE STEP (Lemon, Mint, Pine) Detergent for Cleaning, Disinfecting and Deodorizing Description One Step is an effective economical 4 ounce per gallon disinfectant, specifically
More informationSurveillance will occur in all inpatient locations in Kuwait Ministry of Health hospitals.
Urinary Tract Infection (Catheter-Associated Urinary Tract Infection [CAUTI] Non-Catheter-Associated Urinary Tract Infection [UTI]) Other Urinary System Infection [USI]) Events Settings: Surveillance will
More informationSILVERTOUCH FOLEY CATHETER
SILVERTOUCH FOLEY CATHETER THE STANDARD FOR SILVER Important National Initiatives 2009 CDC Guidelines for Prevention of Catheter Associated UTIs APIC Vision 2012 Joint Commission National Patient Safety
More informationPEACEHEALTH LABORATORIES
360-414-2306 www.peacehealthlabs.org Critical Values Call List - Longview Critical values are reported per the criteria published below. Laboratory results meeting these criteria indicate potential life-threatening
More informationAdvanced Training Program Infection Prevention and Control By Dr. Ahmad Farouk EBFM, MRCGP, CIC
Advanced Training Program Infection Prevention and Control By Dr. Ahmad Farouk EBFM, MRCGP, CIC Tel: +973 172 80 8 50 Mobile: +973 343 58 323 Fax: +973 a 11446 Address: BMMI Tower, Office 1423, 14 th Floor,
More informationAntibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005)
Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005) Streptococcus pneumoniae (SP) Blood Culture Isolates Penicillin intermediate Penicillin Cefotaxime 336
More informationUVDI-360. Clinical and Laboratory Evidence. Room Sanitizer. UltraViolet Devices, Inc. UVDI EPA Establishment Number CA-001
UVDI-360 Room Sanitizer Clinical and Laboratory Evidence Designed and Manufactured by Designed and Manufactured UVDI in California, USAUSA by UVDI in California, UVDI EPA Establishment Number 73542-CA-001
More informationHealthcare- Associated Infections: Preventing the Preventable
Healthcare- Associated Infections: Preventing the Preventable HEALTHCARE-ASSOCIATED INFECTIONS: PREVENTING THE PREVENTABLE Course # 516 5 CE Hours Author: Diana Harland, BS, CCRC, Editor: Cheryl Duksta,
More informationKENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #
Inc. Efficacy: Disinfection (at ½ ounce per gallon) Kennel Kare SC is bactericidal according to the AOAC Use Dilution Test method on hard inanimate surfaces modified in the presence of 5% organic serum
More informationRobert A. Weinstein, MD Stroger (Cook County) Hospital Rush Medical College April 6, Disclosure: Grant funding from CDC & Sage Products, Inc.
Robert A. Weinstein, MD Stroger (Cook County) Hospital Rush Medical College April 6, 2010 Disclosure: Grant funding from CDC & Sage Products, Inc. How the BLEEP should I know? Only problem how we gonna
More informationAntimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association
Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association Els Vandecasteele, Jan De Waele, Dominique Vandijck, Stijn Blot, Dirk
More informationCarbapenem-resistant Enterobacteriaceae (CRE): Coming to a hospital near you?
Carbapenem-resistant Enterobacteriaceae (CRE): Coming to a hospital near you? Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust www.reflectionsipc.com @jonotter Contents What s the problem?
More informationMethicillin-Resistant Staphylococcus aureus (MRSA) S urveillance Report 2008 Background Methods
Methicillin-Resistant Staphylococcus aureus (MRSA) Surveillance Report 2008 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services
More informationHYPOCHLOROUS ACID (HOCl) Our Body's immune system protector in a BOTTLE
AQUAOX IS A REVOLUTIONARY DISINFECTION SOLUTION WHICH ACTIVE INGREDIENT HOCL IS NON HAZARDOUS, HAS NO FRAGRANCE, AND IS SAFE ON ALL SURFACES (AND ON SKIN.) HYPOCHLOROUS ACID (HOCl) Our Body's immune system
More informationPrevention of CAUTI is discussed in the CDC/HICPAC document, Guideline for Prevention of Catheter-associated Urinary Tract Infection 4.
Urinary Tract Infection (Catheter-Associated Urinary Tract Infection [CA] and Non-Catheter-Associated Urinary Tract Infection []) and Other Urinary System Infection [USI]) Events Introduction: Urinary
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A AAP. See American Academy of Pediatrics (AAP) Acyclovir dosing in infants, 185 187 American Academy of Pediatrics (AAP) COFN of, 199 204 Amphotericin
More informationOptimum-UV Clinical & Laboratory Evidence
Optimum-UV Clinical & Laboratory Evidence safeguarding patient environments HEALTHCARE TABLE OF CONTENTS Laboratory Micro-Efficacy Testing Proven against more than 30 HAI-causing pathogens in 5 minutes
More informationKENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #
Inc. Efficacy: Hospital Disinfection (at ½ ounce per gallon) Kennel Kare SC is bactericidal according to the AOAC Use Dilution Test method on hard inanimate surfaces modified in the presence of 5% organic
More informationSyndromic Testing: The right test, the first time.
Syndromic Testing: The right test, the first time. Don t guess. Know. Infectious disease diagnostics has evolved. BioFire s syndromic approach is making the world a healthier place. Many infectious diseases
More informationCouncil of Europe: 1974 recomendación de realizar estudios sobre la situación de la IN en Europa
Council of Europe: 1974 recomendación de realizar estudios sobre la situación de la IN en Europa Estudios sobre la situación de la IN en Europa: - DANOP - WHO.CARE - ESICM encuestas - EURO.NIS - EPIC Mostraron
More informationUnderstanding Non-Ventilator-Associated Pneumonia and Other Lower Respiratory Infections Isaac See, MD November 7, 2013
Understanding Non-Ventilator-Associated Pneumonia and Other Lower Respiratory Infections Isaac See, MD November 7, 2013 National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare
More informationFresh Citrus Disinfectant Cleaner
SUMMARY OF ANTIMICROBIAL ACTIVITY Fresh Citrus Disinfectant Cleaner Description Fresh Citrus Disinfectant Cleaner is an effective economical 4 ounce per gallon disinfectant, specifically designed for hospitals,
More informationAPIC NHSN Webinar 9/8/2015. Topic Overview. Overall Learning Objectives
APIC NHSN Webinar Janet Brooks, Cindy Gross, Denise Leaptrot, & Eileen Scalise Subject Matter Experts September 9, 2015 National Center for Emerging and Zoonotic Infectious Diseases Place Descriptor Here
More informationProposals for E.coli surveillance Informatics- proposal for the Infection. VRE molecular epidemiology AMR alerts HPA repatriation Rotavirus
HPS Update Proposals for E.coli surveillance Informatics- proposal for the Infection Intelligence Platform (IIP) VRE molecular epidemiology AMR alerts HPA repatriation Rotavirus IIP Strategic intent.to
More informationInfection Control: Meeting the Challenge
22nd Annual Midas+ User Symposium June 2 5, 2013 Tucson, Arizona Infection Control: Meeting the Challenge Wednesday, June 5, 2:30 pm The data demands placed on Infection Control departments have significantly
More informationNosocomial Infection in a Pediatric Intensive Care Unit in a Developing Country
BJID 2003; 7 (December) 375 Nosocomial Infection in a Pediatric Intensive Care Unit in a Developing Country Marcelo L. Abramczyk 1,2, Werther B. Carvalho 1,2, Eduardo S. Carvalho 2 and Eduardo A. S. Medeiros
More informationBACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year )
BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year 2012-2013) 19. 10. 2012. Introduction in microbiology, bacterial taxonomy, general bacterial prop Bacterial structures, biosynthesis
More informationMicrosan rx Anti-Microbial Healthcare Professional Soap. Organism Positives ATCC #
: Contact Time: 30 seconds 17,500 ppm. PCMX active Organism Positives ATCC # Acinetobacter calcoaceticus var. anitratus 0 s Acinetobacter calcoaceticus var. woffii 0 s Actinobacillus pleuropneumonia 0
More information(Facility Name and Address) (1D) Surveillance of Urinary Tract Infections in the Long-Term Care Setting
Policy Number: 1D Date: 4/16/14 Version: 1 (1D) Surveillance of Urinary Tract Infections in the Long-Term Care Setting Introduction: One-quarter of the older adult population in the United States will
More informationMonitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 30 June 2014
Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 3 June 214 1. The cumulative cases report since December 21 and cases report during April to June 214 During 1 April to 3 June
More informationCentral Line-Associated Infections (CLABSI) Settings Toolkit
Central Line-Associated Infections (CLABSI) in Non-Intensive Care Unit (non-icu) Settings Toolkit Activity C: ELC Prevention Collaboratives Alex Kallen, MD, MPH and Priti Patel, MD, MPH Division of Healthcare
More informationDoes Using a Laparoscopic Approach to Cholecystectomy Decrease the Risk of Surgical Site Infection?
ANNALS OF SURGERY Vol. 237, No. 3, 358 362 2003 Lippincott Williams & Wilkins, Inc. Does Using a Laparoscopic Approach to Cholecystectomy Decrease the Risk of Surgical Site Infection? Chesley Richards,
More informationPotential Reimbursement CPT Codes
BioFire FilmArray Blood Culture Identification (BCID) Panel Medicare All targets (n) 87150 n x * *BioFire BCID Panel is comprised of 27 total targets. The number of targets allowed for reimbursement may
More informationProtocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel
Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel Laboratory Protocols for Use with a ZeptoMetrix NATtrol Verification Panel Purpose The Clinical Laboratory
More informationStreptococci facultative anaerobe
THE GENUS STREPTOCOCCUS The genus Streptococcus obtains Gram-positive cocci, nonmotile, nonsporeforming, arranged mostly in chains or in pairs. Most species are facultative anaerobes. Some of streptococci
More informationTennessee s Tenth Report on Healthcare-Associated Infections: Overview of Report, Methodology, and Format
Tennessee s Tenth Report on Healthcare-Associated Infections: Overview of Report, Methodology, and Format TDH HAI Team September 3, 2015 Acknowledgements THA/TCPS for hosting this webinar TDH HAI Team
More informationMicrobiological Evaluation of Nosocomial Infections by Using National Nosocomial Infection Surveillance (NNIS) System
Arch Pediatr Infect Dis. 2013 October; 1(5): 217-24. Published online 2013 October 27. DOI: 10.5812/pedinfect.10967 Research Article Microbiological Evaluation of Nosocomial Infections by Using National
More informationTied with pneumonia as the second most common type of healthcareassociated
Tied with pneumonia as the second most common type of healthcareassociated infection. > 15% of HAIs reported to NHSN Estimated > 560,000 nosocomial UTIs annually Increased morbidity & mortality Estimated
More informationThis material is supported in part by unrestricted educational grants from: Abbott, Bayer HealthCare, Merck Frosst, Roche Diagnostics, and Wyeth Inc.
Division of Medical Microbiology Department of Laboratory Medicine and Pathology University of Alberta Hospital and Stollery Children's Hospital Antibiogram 2006 This material is supported in part by unrestricted
More informationCatheter Associated Urinary Tract Infection
Catheter Associated Urinary Tract Infection Facts about CAUTI 12% to 16% of adult patients will receive a urinary catheter during hospitalization. 4 th most common HAI Accounts for more than 12% of acute
More informationBactiguard Infection Protection. BIP Foley Catheter. For prevention of healthcare associated infections
Bactiguard Infection Protection BIP Foley Catheter For prevention of healthcare associated infections Bactiguard benefits Reduced healthcare costs Reduced use of antibiotics Save lives Catheter associated
More informationPrevention of CAUTI is discussed in the CDC/HICPAC document, Guideline for Prevention of Catheter-associated Urinary Tract Infection.
Urinary Tract Infection (Catheter-Associated Urinary Tract Infection [CA] and Non-Catheter-Associated Urinary Tract Infection []) and Other Urinary System Infection [USI]) Events Introduction: Urinary
More informationHospital-wide Impact of Mandatory Infectious Disease Consultation on Staphylococcus aureus Septicemia
Hospital-wide Impact of Mandatory Infectious Disease Consultation on Staphylococcus aureus Septicemia Amanda Guth 1 Amy Slenker MD 1,2 1 Department of Infectious Diseases, Lehigh Valley Health Network
More informationM E D I C A L L A B O R A T O R Y
M E D I C A L L A B O R A T O R Y E V A L U A T I O N PARTICIPANT SUMMARY 2 0 1 7 Microbiology 2017 MLE-M1 Total Commitment to Education and Service Provided by ACP, Inc. Evaluation Criteria... 2 Microbiology
More informationby author Epidemiology of infections in the ICU
Epidemiology of infections in the ICU Anastasia Antoniadou Internal Medicine Infectious Diseases Assistant Professor Athens University Medical School University General Hospital ATTIKON Epidemiology of
More informationSupplemental Digital Content
Rapid Diagnosis of Infection in the Critically Ill (RADICAL), a multicenter study of molecular detection in bloodstream infections, pneumonia and sterile site infections Jean-Louis Vincent, David Brealey,
More informationCorrelation of Postoperative Wound Infection with Intraoperative Culture Results and Duration of Operation
POSTOPERATIVE THE IRAQI POSTGRADUATE WOUND INFECTION MEDICAL JOURNAL Correlation of Postoperative Wound Infection with Intraoperative Culture Results and Duration of Operation INTRODUCTION: Infection is
More informationSurveillance of Healthcare-Associated Infections in Adult Patients with Leukemia in Kuwait Cancer Control Center
March 2009 KUWAIT MEDICAL JOURNAL 31 Original Article Surveillance of Healthcare-Associated Infections in Adult Patients with Leukemia in Kuwait Cancer Control Center Abeer Aly Omar 1, Haifaa Al-Mousa
More information